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ABSTRACT 
Over the past decades several studies have investigated the importance of an adequate vitamin E status to sustain both 
animal health and production in dairy cows. Cow milk is considered as a remarkable source of bioactive components 
promoting human health, which has renewed interest in the effects of vitamin E supplementation on its nutritional value, 
sensory quality and shelf life. Thus, defining relative bioavailability, utilisation and transfer into milk of different vita- 
min E formulations is particularly important to assess the adequate levels of supplementation for animal health and 
milk quality. In nature vitamin E is present under one isomeric form, RRR α-tocopherol; when α-tocopherol is synthe- 
sized chemically, a racemic mixture of 8 possible isomers of α-tocopherol in equimolar concentrations is produced 
(all-rac α-tocopherol). The different stereoisomers have different biopotencies in humans and livestock; the conversion 
factor between RRR and all-rac vitamin E was estimated by early studies on the basis of the rat foetal resorption bio- 
assay, and then extended to other species. Recent advances on the distribution of vitamin E stereoisomers in plasma 
and tissues have highlighted the need to formulate new conversion factors in dairy cows as well as in humans. On ac- 
count of this, the present article aims to consider past and recent data related to vitamin E in dairy cow nutrition.  
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1. Introduction 
Vitamin E is one of the most important components of 
cellular antioxidant systems. In nature it is present under 
eight different forms, four tocopherols (α-, β-, γ-, δ) and 
four tocotrienols (α-, β-, γ-, δ), of which α-tocopherol is 
the most bioactive. As an antioxidant, α-tocopherol is 
able to prevent free-radical mediated tissue damage, and 
thus to prevent or delay the development of degenerative 
and inflammatory diseases; in such a role it has been 
extensively investigated in many species, humans in- 
cluded. About dairy cows, several reviews have discussed 
extensively on this topic over the past decades [1-4]. 
According to different surveys vitamin E supplementa- 
tion helps to enhance animal health and production and, 
when dietary selenium is adequate, it significantly re- 
duces the incidence of intramammary infections (IMI) 
and clinical mastitis [5]. Vitamin E also seems to be cru- 
cially involved in immune system function so that sup- 
plementation with supra-nutritional levels of the vitamin, 
at least in some instances, results in improved immune 
responses [4]. These benefits, particularly in a context of 
much-reduced use of fresh forage (vitamin E-rich) in 
dairy cow nutrition, have led to a substantial increase in 
recommended intake levels for this animal [6]. Vitamin E 
supplementation is a common practice in animal nutrition, 
and increasing the feed content of synthetic or natural 
vitamins is the best way to maintain adequate plasma 
levels for animal health.  
Objective of this paper is to consider bioavailability, 
bioactivity and transfer into milk of different vitamin 
forms. First, we discuss the new insights on the utilisa- 
tion of vitamin E isomeric forms and formulations, and 
then we consider the dietary role of vitamin E to improve 
animal health and milk quality. 
2. Vitamin E Bioavailability and Utilisation 
2.1. Natural versus Synthetic Vitamin E 
When α-tocopherol is synthesised chemically, a racemic 
mixture of all 8 possible isomers of α-tocopherol in 
equimolar concentrations is produced (synthetic form, 
also referred as all-rac α-tocopherol and historically la- 
beled dl-α-tocopherol), with four stereoisomers showing 
a 2R configuration (RRR, RRS, RSS, RSR, having R 
configuration at position 2’ of the phytyl tail) and four 
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stereoisomers possessing a 2S configuration (SRR, SSR, 
SRS, and SSS, having S configuration at position 2’ of 
the phytyl tail, Figure 1). Among possible different 
forms of α-tocopherol, RRR α-tocopherol is the only 
isomeric form of vitamin E produced by plants (natural 
form, historically labeled d-α-tocopherol) and is there- 
fore the only one naturally present in feedstuffs.  
Since the free forms are easily oxidized, more stable 
forms―such as acetate and succinate esters of α-toco- 
pherol (RRR α-tocopheryl acetate, RRR α-tocopheryl suc- 
cinate, all-rac α-tocopheryl acetate, all-rac α-tocopheryl 
succinate)―have been synthesized to be used as feed 
additives. The ester forms are very stable to in vitro oxi- 
dation; however, they need to be hydrolysed in the ani- 
mal gut to free tocopherol which exerts its activity in vivo 
[1]. The acetate ester of all-rac α-tocopherol (all-rac 
α-tocopheryl acetate) is the most common form of vita- 
min E supplementations, due to its cost and stability in 
animal feeds.  
The different stereoisomers of vitamin E have different 
biopotencies, with the RRR form having a greater active- 
ity than the all-rac form. The terms biopotency or bioac- 
tivity usually refer to the amount of a nutrient associated 
with some measured physiological endpoints, e.g. pre- 
vention of specific deficiency symptoms [7]. The relative 
activity of RRR and all-rac vitamin E was estimated by 
the United States Pharmacopeia (USP) [8] based on the 
rat foetal resorption bioassay and the USP conversion 
factor of 1.36 equating RRR to all-rac α-tocopheryl ace- 
tate was extended to other species. Recently, the FEEDAP 
Panel (EFSA Panel on Additives and Products or Sub- 
stances used in Animal Feed) confirmed the conversion 
factors stated by USP in 1979 for livestock, reporting 
that all-rac α-tocopheryl acetate, RRR α-tocopherol and 
RRR α-tocopheryl acetate are efficacious in all animal 
species and have different biopotencies: one International 
Unit (IU) of vitamin E is defined as 1 mg all-rac α-to- 
copheryl acetate, as 0.74 mg of RRR α-tocopheryl ace- 
tate and as 0.67 mg of RRR α-tocopherol [9].  
It is noteworthy that in humans the Institute of Medi-
cine (IOM) redefined the USP conversion factors on the 
basis of studies indicating that the 2S stereoisomers of 
all-rac α-tocopherol were not maintained in human 
plasma [10-12] or in tissues [13] and published new 
conversion factors (Table 1), limiting the active form of 
vitamin E to the 2R stereoisomeric forms of α-tocopherol, 
which represent 50% of all-rac α-tocopheryl acetate and 
100% of RRR α-tocopheryl acetate formulations [14].  
Some recent comprehensive reviews of literature data 
suggest that bioavailability of RRR α-tocopheryl acetate 
should be reconsidered for livestock animals as well, and 
that new conversion factors, in line with human studies, 
are needed [15,16]. A suggestion deriving from a deeper 
understanding of bioavailability concerning stereoisom- 
eric forms of vitamin E, achieved by studying their dis- 
tribution in plasma and tissues of various animal species 
by analytical methods based on chiral HPLC procedures 
[15].  
 
 
Figure 1. Natural and synthetic vitamin E. 
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Table 1. Factors for converting International Units of 
vitamin E to α-tocopherol to meet recommended intake in 
humans.  
USP Conversion 
Factorsa [8,15] 
IOM Conversion 
Factorsb [14] Chemical form 
IU/mg mg/IU mg/IU 
all-rac α-tocopheryl acetate 1.00 1.00 0.45 
all-rac α-tocopherol 1.10 0.91 0.45 
RRR α-tocopheryl acetate 1.36 0.74 0.67 
RRR α-tocopherol 1.49 0.67 0.67 
aThe USP conversion factors are based on rat foetal resorption assays con- 
ducted in the 1940s; bThe amounts of acetate compounds are adjusted for 
their different molecular weights relative to α-tocopherol, by dividing the 
mg of the vitamin E compound by its molecular weight (α-tocopheryl ace- 
tate = 472; α-tocopherol = 430) and multiplying by the molecular weight of 
α-tocopherol (430). The activities of the synthetic α-tocopherol compounds 
have been divided by 2 because the 2S stereoisomers contained in synthetic 
α-tocopherol are not maintained in the blood; Source: [14]. 
 
Distribution of α-tocopherol isomers in plasma and 
milk has been recently studied when feeding all-rac or 
RRR forms to periparturient dairy cows. Meglia et al. [17] 
showed that RRR α-tocopherol is the predominant form 
(more than 86% of the total) found in plasma of cows fed 
1000 IU/day of either supplemental all-rac α-tocopheryl 
acetate, RRR α-tocopheryl acetate, or RRR α-tocopherol. 
Weiss et al. [18], after supplementation of 2500 IU/day 
of vitamin E from all-rac α-tocopheryl acetate or RRR 
α-tocopheryl acetate, found concentrations of α-toco- 
pherol in cow plasma ranging from 1.2 to 1.4 times greater 
for RRR treatment than for all-rac treatment.  
In both studies, very low concentrations of 2S isomers 
were detected in plasma of cows fed all-rac α-tocopheryl 
acetate. As the 2S isomers represent 50% of the isomers 
present in the all-rac α-tocopherol, such data suggest that 
1 g of all-rac α-tocopheryl acetate is equivalent to 0.5 g 
of RRR α-tocopheryl acetate in dairy cows.  
A study evaluating plasma concentration and distribu- 
tion of α-tocopherol stereoisomers after intramuscular 
injection of 2.5 g all-rac α-tocopheryl acetate [19] evi- 
denced difference in turnover rate of different stereoi- 
somers in cow plasma: the 2S stereoisomers had showed 
the faster disappearance from blood compared to the 
other forms; however, considering the plasma concentra- 
tion of stereoisomers one day after injection, the 2S 
forms showed also a faster increase related to their initial 
level, when compared to the other forms. Based on plasma 
concentrations at 10 days after injection, Dersjant-Li and 
Peisker [20] calculated a higher relative bioavailability of 
RRR α-tocopheryl acetate over all-rac α-tocopheryl ace- 
tate. However, considering that plasma distribution of 
stereoisomers is different over time, sampling time (e.g. 
day 1 or day 5) chosen to determine the relative bioavail- 
ability is crucial. As a general rule, the ratio of bioavail- 
ability, being not constant but variable [21], should be 
estimated considering the plasma profile over time (and 
relative area under the concentration curve, AUC) rather 
than on a single timepoint.  
Methodologies used in the evaluation of α-tocopherol 
forms bioavailability frequently diverge according to 
different studies, making it difficult to compare some- 
times dissimilar results [20]. To estimate true relative 
bioavailability of RRR over all-rac α-tocopheryl acetate, 
it is also important to consider the contribution given by 
α-tocopherol originating from basal ingredients, consist- 
ing only of RRR form and responsible for the basal 
plasma level.  
Bioactivity underpinning different bioavailability of 
vitamin E isomers is still under debate. In fact, the RRR 
form, while being more bioavailable, does not appear to 
affect neutrophil phagocytosis and killing. In the previ- 
ously-mentioned study, Weiss et al. [18] found that, al- 
though cows fed on supplemental RRR α-tocopherol 
showed higher concentration of α-tocopherol in neutron- 
phils, phagocytosis was greater in neutrophils from cows 
supplied with supplemental all-rac vitamin E (Table 2).  
Not only its chemical form, but also different formula- 
tions and delivery systems can greatly affect vitamin E 
bioavailability [22-24]. A formulation can have a major 
influence on intestinal availability of vitamin E, which in 
dairy cows may be limited by ruminal degradation. En- 
capsulation technologies made it possible to formulate 
products that deliver specific nutrients to small intestine 
absorption sites by protecting them from degradation 
within the rumen. Baldi et al. [23] compared the phar- 
macokinetic parameters of vitamin E after intraruminal 
administration of oil-based, silica-adsorbed and micro- 
encapsulated preparations and found that all-rac α-to- 
copheryl acetate adsorbed on silica or microencapsulated  
 
Table 2. Effect of supplemental vitamin E (2500 IU) on 
concentration of total α-tocopherol in blood neutrophils and 
neutrophil function. 
 Control RRR All-rac SE 
α-tocopherol in 
neutrophils 
(ng/106 cells)1
2.71a 5.84b 4.62b 0.61 
Phagocytosis2 5.08a 4.92a 5.68b 0.18 
Kill, %3 86 84 84 1.5 
Kill index4 3.94a 3.72a 4.34b 0.14 
a,bMeans in same row with different superscripts differ (P < 0.05); 1neutrophils 
were collected from cows at 3 DIM; 2number of bacteria (dead or alive) 
within a neutrophil; 3percentage of phagocytized bacteria that are dead; 
4(positive/100) × (kill/100) × bacteria/neutrophil; Source: [18].  
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resulted in different pharmacokinetic profiles and in a 
greater relative bioavailability than the oil-based prepara- 
tion. Bontempo et al. [24], after oral administration of 
α-tocopherol in oil, encapsulated in liposomes or cyclo- 
dextrin, found that encapsulated preparations had a 
longer persistence in blood and a slightly greater avail- 
ability than the oil-based preparation.  
In general, it has been observed (Table 3) that plasma 
total response (AUC) increases linearly with increasing 
dose, while the maximal plasma α-tocopherol reached 
does not increase to the same extent.  
2.2. Vitamin E Interactions with Other Nutrients 
Vitamin E interacts with other nutrients that can influ- 
ence its bioavailability. Several papers have examined 
this topic deeply, as reported below. Vitamin E absorp- 
tion is closely tied to the digestion and absorption of fats, 
thus the type and amount of fat in the gut has an impor- 
tant influence on the absorption efficiency of the vitamin. 
Mid-lactation cows receiving 25, 125 or 250 IU of vita- 
min E and diets containing no supplemental fat or 2.25% 
added fat from roasted soybeans or tallow, showed a rate 
of increase of plasma α-tocopherol 1.9 greater when fat 
was supplemented [25]. Nevertheless, Baldi et al. [26] 
showed that when 0.2 kg/day of calcium-soaps (relative 
to isoenergetic starch) were fed to early lactation dairy 
cows in addition to vitamin E, this had no effect on the 
vitamin E status. These different results can be explained 
in two ways: first, the amount of fat in the basal diet may 
affect vitamin E absorption efficiency and, hence, plasma 
levels; second, absorption might also be affected by dif- 
ferences in the rate of digesta flow through the gut at 
different stages of lactation. 
Dairy cows receiving 20 g/day of rumen-protected 
choline showed higher plasma concentrations of α-to- 
copherol than control cows during the first 30 days of 
lactation (2.46 vs. 1.85 μg/ml), suggesting that choline 
supply can reduce the physiological drop of vitamin E in 
the transition period [27]. The mechanism by which cho- 
line maintains vitamin E levels in this period has not 
been completely understood yet. Anyway, as α-toco-  
pherol is preferentially incorporated in to nascent VLDLs, 
a reasonable hypothesis is that choline, a vital component 
of lipoproteins, influences vitamin E status by promoting 
VLDL formation [28].  
Bioactivity of vitamin E is closely related to the sup- 
plementation of adequate dietary levels of other nutrients 
involved in the cell antioxidant system. In particular, as 
an integral component of the enzyme glutathione per- 
oxidase (GSH), selenium is important to maintain proper 
levels of the components of the tissue defence mecha- 
nisms against free-radical damage and its metabolic 
function is closely linked to vitamin E. When vitamin E 
exerts its antioxidant activity it is converted into toco- 
pheroxyl radical that needs to be converted back to to- 
copherol in order to prevent α-tocopherol free-radical 
related damage. Regeneration of tocopherol involves 
multiple reactions and interacting molecules [29], in- 
cluding vitamin C and the selenium-containing enzyme 
GSH. 
Several studies have shown that contemporary admini- 
stration of vitamin E and selenium may result into a syn- 
ergistic enhancement of both immune response and dis- 
ease resistance in domestic animals, particularly in ru- 
minants [30,31]. In dairy cows, selenium nutritional re- 
quirement is 0.3 mg/kg dry matter [6] and selenium sup- 
plements are available in form of inorganic mineral salts, 
such as sodium selenite or selenate and organic forms, 
such as selenium-enriched yeasts. Effects of selenium 
supplementation on immune function and bovine mam- 
mary gland health have been recently reviewed by Sal- 
man et al. [32] and scientific evidence related to the ef- 
fect of oral supplementation of organic and inorganic 
forms on milk selenium concentration in cattle have been 
summarised by a systematic review and meta-analysis 
[33].  
3. Vitamin E Function and Activity 
3.1. Vitamin E and Mammary Gland Health  
Based on health and immune function in cows, vitamin E 
intake has been generally considered adequate when 
α-tocopherol plasma levels are above 3 - 3.5 µg/ml. In  
 
Table 3. Pharmacokinetic parameters of α-tocopherol after intraruminal administration of dl-α-tocopherol or dl-α-tocopheryl 
acetate in oil-based (O) and microencapsulated (M) preparations. 
dl-α-tocopherol dl-α-tocopheryl acetate 
 
O M O M 
Maximum concentration (μg/ml) 4.86 ± 0.49 5.03 ± 0.39 4.08 ± 0.21 3.29 ± 0.14 
Final concentration (μg/ml) 1.97 ± 0.47 2.61 ± 0.33 2.58 ± 0.30 2.66 ± 0.22 
Area under curve (μg/ml/h) 496 ± 54.0 547 ± 26.7 465.4 ± 38.7 620.25 ± 108.5 
D   ata are means ± SE. Source: [4]. 
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order to maintain these blood values, non-grazing dairy 
cows are suggested to be fed on 1000 international units 
(IU) of supplemental vitamin E daily during the dry pe- 
riod and 500 IU during lactation [6]. 
It is established that plasma vitamin E levels fall sig- 
nificantly around parturition in dairy cows so that it is 
difficult to maintain levels considered adequate for their 
health in this period.  
During the periparturient period, dairy cows experi- 
ence alterations in immune responsiveness and a cones- 
quent greater susceptibility to various metabolic and in- 
fectious diseases including mastitis, metritis and retained 
foetal membranes. Several components of the host de- 
fence system are impaired during this period, in particu- 
lar a decreased activity of neutrophils has been associ- 
ated with increased susceptibility to mastitis [34,35].  
Several studies reported positive effects of supple- 
mentation with supranutritional levels of vitamin E on 
the immune system, specifically a higher killing ability, 
superoxide production and u-PA activities of neutrophils 
and improved macrophage function [36-42].   
Benefits of vitamin E and selenium supplementation in 
this critical period on mammary gland health have been 
registered since 1984 [43] and most of the studies pub- 
lished over the past decades clearly indicate that ade- 
quate dietary vitamin E and selenium intakes, above nor- 
mal nutritive requirements and supplemented during the 
dry period, reduce milk SCC and influence the preva- 
lence and severity of IMI in dairy herds [26,42,44,45]. A 
recent meta-analysis [5] of 34 papers published between 
1984 and 2003 that addressed the relationship between 
vitamin E and udder health, confirmed that different lev- 
els of supplementation, up to a maximum of 4000 IU dur- 
ing the dry and early lactation periods, were associated 
with lower IMI, somatic cell counts (SCCs) and clinical 
mastitis. On average, vitamin E supplementation was 
associated with a 14% reduction in the risk of IMI, with a 
reduction of milk SCC by a factor of 0.70 and a 30% 
decrease in the risk of occurrence of clinical mastitis. 
Other studies showed no positive effects of vitamin E 
supplementation on udder health. LeBlanc et al. [46] 
found no association between serum α-tocopherol con- 
centration after injection of 3000 IU of vitamin E one 
week before expected calving and the risk of mastitis at 
or soon after calving. Similarly, a study [47] performed 
in European commercial dairy herds with a high inci- 
dence of veterinary-treated clinical mastitis did not find 
any significant effect of extra daily supplementation of 
1610 mg of RRR α-tocopheryl acetate around calving on 
udder health or on other cow health problems.  
A recent experiment conducted on five farms with his- 
torically high rates of mastitis in the Netherlands re- 
ported for the first time higher incidences of clinical and 
subclinical mastitis in cows receiving a daily supplement 
of 3000 IU of vitamin E during the dry period, compared 
to cows receiving a daily supplement of 135 IU [48]. The 
mean vitamin E level at dry off for the cows involved in 
this study was 2 to 3 times higher than starting levels for 
cows in other studies [46,49] and in the opinion of the 
authors this is the most reasonable explanation for the 
results observed. In this study, an initial blood vitamin E 
level at dry off above 6.42 μg/ml was considered a risk 
factor for developing clinical mastitis. However in an- 
other study with average blood vitamin E levels equal to 
or higher than 6 μg/ml during the periparturient period, a 
positive rather than negative effect of supplementation on 
the immune function and SCC/ml levels in milk was 
found [41]. 
The plasma concentration of α-tocopherol at dry off is 
obviously a critical factor in determining the positive 
effect of vitamin E supplementation on the incidence of 
mastitis. Additionally, different levels of oxidative stress 
may explain the variation in results from different studies. 
As previously discussed, the importance of establishing 
the levels of other nutrients interacting with vitamin E 
has to be considered to determine whether supplementa- 
tion will be beneficial or not [29,50]. Finally, differences 
in the conclusions from different studies may be ex- 
plained by differences in farm management, differences 
in the way vitamin E is supplemented (oral v. i.m. inject- 
tion), and even in the type of microorganism causing the 
disease. 
3.2. Vitamin E and Milk Quality 
It is well known that vitamin E supplementation has a 
positive effect not only on animal health, but also on milk 
quality. Results from most studies [26,39,42] strongly 
suggest that high levels of vitamin E supplementation 
(2000-3000 UI/cow per day) during the periparturient 
period are effective in reducing milk SCC by about 29% 
in treated cows.  
Furthermore, as an antioxidant vitamin E helps to slow 
lipid peroxidation and to maintain oxidative stability and 
flavour of milk. Several studies reported a positive effect 
of vitamin E on oxidative stability of milk [51-53]. Bo- 
vine milk is susceptible to auto-oxidation when the level 
of vitamin E falls below 20 μg/g of fat [54] and this leads 
to the development of an “oxidised flavour” (OF), de- 
scribed as cardboard-like, metallic or tallow-like. The 
fatty acid profile of milk fat is a major factor in the de- 
velopment of OF, and milk with a high concentration of 
polyunsaturated fatty acids, as linoleic or linolenic acid, 
is more likely to develop OF [55]. Recently, there has 
been a considerable interest in developing specific ani- 
mal feeding regimes in order to increase the polyunsatu- 
rated lipid content of milk, and in particular the content 
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of fatty acids thought to benefit human health, such as 
conjugated linoleic acids. Milk with a high content of 
these lipids may benefit human health, but at the same 
time is more vulnerable to oxidation. In this context, in- 
creasing the vitamin E content of milk may represent a 
useful way to protect lipids from peroxidation and to 
maintain nutritional and organoleptic qualities of milk. It 
has also been shown that the uptake of plasma vitamin E 
by the mammary gland of dairy cows increases when 
diets enriched in polyunsaturated fatty acids are fed [56].  
Available data on the amount of supplemental vitamin 
E required to ensure oxidative stability of milk with a 
high unsaturated fat content are not conclusive. Weiss 
[55] suggested supplementing at least 3000 IU of vitamin 
E per day, when OF is a problem. By contrast, Slots et al. 
[57] found that supplementation of the feed with 2600 
and 3400 IU of all-rac α-tocopheryl acetate for 16 days 
did not improve oxidative stability of milk.  
Although several studies [25,26,55] indicated that 
transfer of vitamin E from feed to milk is low, around 
1.6% - 2.2%, supra-nutritional supplementation to transi- 
tion cows can increase the vitamin E content of milk 
(Figure 2). Vitamin E supplementation at 2000 UI/day 
from 14 days before expected calving to 7 days after was 
found to produce an increase of vitamin E content of 
milk of about 40%, compared to supplementation at 1000 
UI/day [26].  
The rather low transfer efficiency of α-tocopherol in 
milk could also be dependent on the form of vitamin E 
supplemented. In the previously-mentioned studies [17, 
18], the distribution of α-tocopherol stereoisomers in 
milk in relation to the supplementation of natural and 
synthetic vitamin E to periparturient dairy cows has also 
been investigated. Data from these studies showed that 
concentrations of α-tocopherol in milk was 1.24 to 1.43 
times greater for cows fed the RRR supplement com- 
pared to cows fed the all-rac supplement. Moreover, 
irrespective of dietary treatment, α-tocopherol with natu- 
ral stereochemistry (RRR) was by far the most predomi- 
nating form in milk of cows (at least 86% of the total, 
[17]). Similarly, Slots et al. [57] reported that after sup- 
plementation with 2600 IU and 3400 IU of all-rac α- 
tocopheryl acetate, only the four 2R stereoisomers were 
excreted into the milk, with the RRR isomer dominating 
over others (84.3% and 88% of the isomers, respect- 
tively). 
A preferential uptake or transfer of the RRR form from 
plasma into milk is also suggested by recent studies in- 
vestigating the effect of farming system type on vitamin 
E content of milk. Even in the absence of feed supple- 
mentation with synthetic vitamins, milk and milk prod- 
ucts from organic farms were found to contain more or as 
much vitamin E than conventional milk [60-62] and  
 
Figure 2. Milk content of vitamin E in relation to levels of 
vitamin E supplementation in dairy cows. Data from [17,18, 
25,26,57-59]. 
 
concentrations of the 2R stereoisomers in milk were not 
significantly different between high- and low-input con- 
ventional systems and organic low-input system [63]. 
High levels of vitamin E are effective in maintaining 
milk quality and safety in general, and a further advan- 
tage in increasing vitamin content of milk by animal nu- 
trition rather than fortification is that it contributes to 
animal health safeguard, a primary factor in determining 
safety, quality and health benefits of food of animal ori- 
gin [64]. 
4. Conclusion and Implications 
Defining the relative bioequivalence between RRR and 
all-rac forms is fundamental to determine proper rec- 
ommended intakes of different supplemental forms of 
vitamin E on the basis of α-tocopherol conversion factors, 
in dairy cows as in humans. 
In literature, recent data clearly show that bioavailabil- 
ity of RRR α-tocopheryl acetate relative to all-rac α- 
tocopheryl acetate in dairy cows is 2:1. Nonetheless, the 
use of bioavailability studies in order to determine the 
ratio of potency of the different vitamin E stereoisomers 
is currently under debate. In the absence of clinical end- 
points, no studies have been performed in cattle and pigs, 
as well as in humans, to assay the potency of RRR rela- 
tive to all-rac α-tocopherol so far. On one hand, being 
bioavailability a precondition for any biological activity, 
some authors based the determination of utilisation effi- 
ciency and efficacy of vitamin E stereoisomers on bio- 
availability studies. Other authors disagree with such 
inference arguing that, as RRR and all-rac are not 
chemically identical, any ratio of bioavailability calcu- 
lated in this way cannot be a valid substitute for the ratio 
of potency. Indeed, as discussed above, a greater bio- 
availability of the RRR form does not necessarily corre- 
spond to a higher bioactivity, as evidenced by no effect 
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of this form shown on neutrophil function. Furthermore, 
an essential requisite frequently not considered in vita- 
min E feeding trials for the estimation of the true relative 
bioavailability of RRR over all-rac α-tocopheryl acetate, 
is the correction of α-tocopherol intake originating from 
basal ingredients. 
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